Pell Bio-Med Technology Cash Flow Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-423.94	-389.42	-398.76	-230.13	-188.96
Depreciation & Amortization	47.12	46.28	45.4	30.38	29.28
Other Amortization	-	0.6	0.22	0.66	0.88
Loss (Gain) From Sale of Assets	-	0.14	0.13	-	0.2
Loss (Gain) From Sale of Investments	-5.13	0.62	-	-	-
Loss (Gain) on Equity Investments	0	-0.11	-0.11	0	-0.01
Stock-Based Compensation	75.12	58.97	143.06	46.68	24.96
Provision & Write-off of Bad Debts	-	-	-	0.07	-
Other Operating Activities	-29.44	-6.8	-2.98	-1.15	-
Change in Accounts Receivable	-1.31	3.85	-1.56	-1.62	-3.39
Change in Inventory	-0.44	-2.42	0.82	-0.34	7.15
Change in Accounts Payable	1.24	-2.53	1.42	2.42	-5.07
Change in Unearned Revenue	-	-	-	-0.75	-
Change in Other Net Operating Assets	55.49	30.69	32.37	-7.2	27.13
Operating Cash Flow	-281.29	-260.12	-179.99	-160.98	-107.84
Capital Expenditures	-226.41	-263.79	-16.49	-6.5	-14.48
Sale of Property, Plant & Equipment	-	1	3.49	-	0.05
Sale (Purchase) of Intangibles	-1.19	-0.19	-	-2	-
Investment in Securities	-290.31	228.72	-402.15	-536	100
Other Investing Activities	20.78	-61.25	-4.49	-6.46	-1.67
Investing Cash Flow	-497.14	-95.51	-419.63	-550.96	83.9
Short-Term Debt Issued	-	200	-	5	-
Total Debt Issued	-	200	-	5	-
Short-Term Debt Repaid	-100	-	-5	-	-
Long-Term Debt Repaid	-27.55	-25.65	-25.07	-10.76	-10.26
Total Debt Repaid	-127.55	-25.65	-30.07	-10.76	-10.26
Net Debt Issued (Repaid)	-127.55	174.35	-30.07	-5.76	-10.26
Issuance of Common Stock	569.32	331.17	625.77	759.34	5.02
Repurchase of Common Stock	-	-	-0.8	-	-
Other Financing Activities	216	109.8	-	14.99	-
Financing Cash Flow	657.76	615.32	594.89	768.56	-5.23
Net Cash Flow	-120.67	259.69	-4.73	56.62	-29.17
Free Cash Flow	-507.7	-523.91	-196.48	-167.48	-122.32
Free Cash Flow Margin	-1615.65%	-2668.77%	-1089.53%	-976.14%	-875.12%
Free Cash Flow Per Share	-8.66	-9.18	-4.25	-4.27	-3.68
Cash Interest Paid	2.05	2.26	2.56	1.36	1.52
Cash Income Tax Paid	0.42	1.2	0.5	0	-
Levered Free Cash Flow	-310.47	-388.73	-53.62	-86.4	-
Unlevered Free Cash Flow	-309.19	-387.32	-52.02	-85.55	-
Change in Working Capital	54.98	29.6	33.05	-7.49	25.81

Source: S&P Global Market Intelligence. Standard template. Financial Sources.